First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY
Journal article
Hopcroft LE. et al, (2023), Wellcome Open Research, 8, 70 - 70
A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection.
Journal article
Calvert C. et al, (2023), Nat Commun, 14
Confirmed SARS-CoV-2 infection in Scottish neonates 2020-2022: a national, population-based cohort study.
Journal article
Goulding A. et al, (2023), Arch Dis Child Fetal Neonatal Ed
Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review.
Journal article
MacKenna B. et al, (2022), JMIR Med Inform, 10
A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection
Journal article
Calvert C. et al, (2022), Nature Communications, 13
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY
Journal article
Green A. et al, (2022), BMC Medicine, 20
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
Journal article
Stock SJ. et al, (2022), The Lancet. Respiratory medicine, 10, 1129 - 1136
Tyrosine Kinase Inhibitor Independent Gene Expression Signature in CML Offers New Targets for LSPC Eradication Therapy
Journal article
Gómez-Castañeda E. et al, (2022), Cancers, 14
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
Journal article
Horne EMF. et al, (2022), BMJ (Clinical research ed.), 378
Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP
Preprint
Hulme W. et al, (2022)
Trends, variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY
Preprint
The OpenSAFELY Collaborative None. et al, (2022)
SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland
Journal article
Stock SJ. et al, (2022), Nature Medicine
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
Journal article
Stewart GD. et al, (2022), British Journal of Cancer
Author Correction: SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland (Nature Medicine, (2022), 10.1038/s41591-021-01666-2)
Journal article
Stock SJ. et al, (2022), Nature Medicine
Tyrosine kinase inhibitor independent gene expression signature in CML offers new targets for LSPC eradication therapy
Preprint
Gómez-Castañeda E. et al, (2022)
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELY
Preprint
The OpenSAFELY Collaborative: None. et al, (2021)